Russia’s sovereign wealth fund said on Friday it had inked a deal with South Korea’s GL Rapha for the biotechnology firm to produce over 150 million doses per year of the Sputnik V coronavirus vaccine.
The South Korean firm is expected to begin production next month, with a roll-out to start in January 2021, the Russian Direct Investment Fund said in a statement. The doses, produced in South Korea, will be intended for global distribution, it said.
Also Read
-
Coronavirus: UK removes UAE, Bahrain from COVID-19 travel quarantine list
Travelers arriving in the United Kingdom from the United Arab Emirates, Bahrain and six other countries will no longer need to quarantine for 14 days ... Coronavirus -
Coronavirus: COVID-19 death rate down 30 pct since April, study finds
The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researchers at the ... Coronavirus -
Coronavirus: Israel says it will sign deal for Pfizer COVID-19 vaccine
Israel will sign a provisional deal with Pfizer Inc on Friday to receive 8 million doses of the drugmaker's still-experimental coronavirus vaccine as ... Coronavirus -
Coronavirus: US Feds announce COVID-19 vaccine agreement with drug stores
Federal health officials have reached an agreement with pharmacies across the US to distribute free coronavirus vaccines after they are approved and ... Coronavirus
